Trial no.:
|
PACTR202404884596632 |
Date of Approval:
|
08/04/2024 |
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
TRIAL DESCRIPTION |
Public title
|
Maternal and neonatal effects of different umbilical cord clamping method after delivery in Ilorin: A randomised control study.
|
Official scientific title |
Maternal and neonatal effects of different umbilical cord clamping method after delivery in Ilorin: A randomised control study.
|
Brief summary describing the background
and objectives of the trial
|
BACKGROUND: Anaemia remains the leading cause of morbidity and mortality among neonates, infants and children less than 5years; of which, iron deficiency anaemia is responsible for than 50%. Placental transfusion through delayed cord clamping or umbilical cord milking could improve neonatal iron store by 40-50mg/kg body weight. Delayed cord clamping is recommended for both preterm and term neonates. However, early umbilical cord clamping is what is being practiced in many hospitals in developing countries owning to understaffing of our labour wards. Umbilical cord milking could serve as an effective alternative to delayed cord clamping. However, there is paucity of studies that assess the safety and efficacy of umbilical cord milking in our environment.
OBJECTIVE: To determine the maternal and neonatal effects of different umbilical cord clamping methods after delivery among term neonates.
STUDY DESIGN: The study would be a two-tailed equality randomized control study.
METHODS: A total of 168 mother-neonate pairs following maternal informed consent would be assigned to either early cord clamping, delayed cord clamping or umbilical cord milking with 56 participants in each group. Participants in early cord clamping group will have the umbilical cord clamped immediately after delivery, clamping will be at one minute after delivery for the delayed cord clamping group while those assigned to umbilical cord milking will have the umbilical cord milked three times after delivery before clamping. Haemoglobin concentration and serum bilirubin levels will be assessed for all neonates at 24-48hours after delivery as well as maternal haemoglobin level.
The primary outcome would be the mean neonatal haemoglobin concentration at 24-48 hours and mean duration of third stage of labour while the secondary outcome measures would be the mean serum bilirubin level, estimated blood loss and need for maternal blood transfusion.
|
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Obstetrics and Gynecology,Paediatrics,Pregnancy and Childbirth |
Sub-Disease(s) or condition(s) being studied |
maternal blood losss after delivery to rule out postpartum haemorrhage |
Purpose of the trial |
elicit diffeent method of cord clamping after delivery |
Anticipated trial start date |
25/01/2024 |
Actual trial start date |
25/01/2024 |
Anticipated date of last follow up |
31/03/2024 |
Actual Last follow-up date |
|
Anticipated target sample size (number of participants) |
168 |
Actual target sample size (number of participants) |
|
Recruitment status |
Recruiting |
Publication URL |
|
|